JENBURKT PHARMACEUTICALS
Back to Cashflow Statement
|
JENBURKT PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-7.62 Cr | ₹-7.08 Cr | ₹-21 Cr | ₹-5.53 Cr | ₹-0.71 Cr |
What is the latest Cash Flow from Financing Activities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-7.62 Cr |
| Mar2024 | ₹-7.08 Cr |
| Mar2023 | ₹-21 Cr |
| Mar2022 | ₹-5.53 Cr |
| Mar2021 | ₹-0.71 Cr |
How is Cash Flow from Financing Activities of JENBURKT PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-7.62 Cr | Negative | |
| Mar2024 | ₹-7.08 Cr | Negative | |
| Mar2023 | ₹-21 Cr | Negative | |
| Mar2022 | ₹-5.53 Cr | Negative | |
| Mar2021 | ₹-0.71 Cr | - | |
Compare Cash Flow from Financing Activities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹518.5 Cr | -0.8% | 1.6% | -10.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,639.0 Cr | 0.9% | -3.1% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,647.0 Cr | 2% | -2.1% | -0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,366.0 Cr | -2.9% | -0.3% | 36.4% | Stock Analytics | |
| CIPLA | ₹109,528.0 Cr | -2.4% | -3.8% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,819.0 Cr | -0.5% | -5% | -6.9% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | -0.8% |
1.6% |
-10.4% |
| SENSEX | 4.9% |
2.8% |
-6.2% |
You may also like the below Video Courses